This week, Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical stage drug development company targeting rare, chronic, and serious inflammatory and…
Kara Elam
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Kara Elam
Recently, a group of researchers from University of British Columbia in Vancouver, Canada released study results in which they found that…
A study recently published in the on-line journal Clinical and Experimental Rheumatology is challenging the clinical assumptions that…
Researchers from the Hunter Holmes McGuire VA Medical Center, Richmond, VA, and the Department of Rheumatic and…
A multi-national team of researchers attempting to find precise clinical indicators that would increase post-diagnosis survival times among patients…